| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.062 | 0.2 |